106 related articles for article (PubMed ID: 29064131)
1. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain.
Nagamine T
Psychiatry Clin Neurosci; 2018 Jan; 72(1):45-46. PubMed ID: 29064131
[No Abstract] [Full Text] [Related]
2. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Nagamine T
Asian J Psychiatr; 2020 Apr; 50():102031. PubMed ID: 32272360
[No Abstract] [Full Text] [Related]
3. Duloxetine-Associated Acute Laryngeal Dystonia: A Case Report.
Dagklis IE; Rokkou I; Kazis D; Bostantjopoulou S
J Clin Psychopharmacol; 2019; 39(6):678-679. PubMed ID: 31688398
[No Abstract] [Full Text] [Related]
4. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
Gicquel C; Moulis F; Chenaf C; Gouraud A; Drici M; Bondon-Guitton E; Montastruc F; Montastruc JL
Eur J Clin Pharmacol; 2017 Sep; 73(9):1197-1198. PubMed ID: 28639120
[No Abstract] [Full Text] [Related]
5. Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.
Aktürk Esen S; Gül CB; Kahvecioğlu S; Aktaş N; Esen İ
J Clin Psychopharmacol; 2019; 39(3):279-281. PubMed ID: 30908353
[No Abstract] [Full Text] [Related]
6. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine lessens joint pain in early-stage breast cancer.
Tanday S
Lancet Oncol; 2017 Jan; 18(1):e10. PubMed ID: 27989429
[No Abstract] [Full Text] [Related]
8. Dysosmia and dysgeusia associated with duloxetine.
Yoshida K; Fukuchi T; Sugawara H
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170185
[TBL] [Abstract][Full Text] [Related]
9. Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.
Henry NL; Unger JM; Till C; Schott AF; Crew KD; Lew DL; Fisch MJ; Moinpour CM; Wade JL; Hershman DL
Cancer; 2019 Jun; 125(12):2123-2129. PubMed ID: 30861098
[TBL] [Abstract][Full Text] [Related]
10. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
Islin J; Munkboel CH; Styrishave B
Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
[TBL] [Abstract][Full Text] [Related]
11. [Duloxetine Associated Galactorrhea and Hyperprolactinemia: A Case Report].
Özkan HM
Turk Psikiyatri Derg; 2020; 31(4):294-296. PubMed ID: 33454942
[TBL] [Abstract][Full Text] [Related]
12. Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain).
Strauss DH; Santhanam DR; McLean SA; Beaudoin FL
BMJ Open; 2019 Mar; 9(3):e025002. PubMed ID: 30842115
[TBL] [Abstract][Full Text] [Related]
13. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
Cutler N
Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28196312
[No Abstract] [Full Text] [Related]
14. Antidepressants May Make for Depressing Surgery.
Oberg TJ; Eftekhari K; Anderson RL
Ophthalmic Plast Reconstr Surg; 2015; 31(4):334. PubMed ID: 26164037
[No Abstract] [Full Text] [Related]
15. Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa.
Pham H; Gosselin-Lefebvre S; Pourshahnazari P; Yip S
CMAJ; 2020 Nov; 192(45):E1403-E1406. PubMed ID: 33168762
[No Abstract] [Full Text] [Related]
16. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
Bellantuono C; Vargas M; Mandarelli G; Nardi B; Martini MG
Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
[TBL] [Abstract][Full Text] [Related]
18. A Case of Aggressive Psychosis in the Setting of Regular Dextromethorphan Abuse.
Okland T; Shirazi M; Rylander M; Holland J
Psychosomatics; 2016; 57(6):655-656. PubMed ID: 27814836
[No Abstract] [Full Text] [Related]
19. Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors.
Varelas AI; Fürst S; Langner C
Virchows Arch; 2022 Nov; 481(5):779-783. PubMed ID: 35655103
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine Induced Hyponatremia.
Şahan E; Parlakkaya Yıldız FB
Turk Psikiyatri Derg; 2019; 30(4):287-289. PubMed ID: 32594491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
